Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Brooks Laboratories Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: BROOKS Small Cap ISIN: INE650L01011
As on 26 February 2025 at 07:51 IST
As on 26 February 2025 at 07:51 IST
115.97
-3.78
(-3.16%)
Over 1 Month
-26.91%
Over 6 Months
-12.91%
Over 1 Year
-5.48%
Over 3 Years
36.31%

Brooks Laboratories Ltd Summary

Close ₹ 115.97
Open ₹ 123.72
High ₹ 123.72
Low ₹ 115.31
Volume 28,287
Net Turnover (in ₹ Cr) ₹ 0.33
52Wk High ₹ 198.86
52Wk Low ₹ 73.25
52Wk High / Low
73.25
198.86

Brooks Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 304.38
EPS (TTM) 0.67
Book Value (BV) 26.77
Div. Yield -
P/E (TTM) 175.22
Price/Book Value 4.38
Delivery % 65.27 %
Face Value 10

Key Ratios

PE Ratio 160
PB Ratio 3.50
EV to Sales 3.13
PEG Ratio -1.36
ROA 2
ROE 1.90
Debt-Equity 0.10
Net Profit Margin 1.92
Operating Profit Margin 5.25

Brooks Laboratories Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue80.4463.4291.9977.98-
Total Expenses78.8998.83115.8886.97-
Profit Before Tax-19.57-38.37-23.90-8.99-
Profit After Tax-19.59-31.05-19.31-19.38-
Operating Profit after Depreciation2.40-33.23-20.80-5.89-

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets13.6715.01110.01107.71-
Total Non Current Assets59.4081.99134.73114.72-
Total Current Assets31.0527.6161.1847.36-
TOTAL ASSETS90.45109.60195.91162.08-
Total Shareholder's Fund65.5973.9587.4979.15-

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities-9.68-14.49-37.444.46-
Net Cash used in Investing Activities0.180.49-24.91-5.13-
Net Cash used in Financing Activities9.6011.4164.071.16-

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue80.4455.6577.9178.2370.09
Total Expenses78.8963.8477.2586.6783.61
Profit Before Tax1.55-8.180.67-8.44-13.51
Profit After Tax1.53-8.180.67-15.59-24.38
Operating Profit after Depreciation2.40-7.421.34-5.19-10.16

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets13.6715.0115.1414.98113.13
Total Non Current Assets63.3464.8266.4267.65119.95
Total Current Assets31.0527.6137.0425.3437.92
TOTAL ASSETS94.3992.42103.4593157.86
Total Shareholder's Fund69.5356.786564.2198.42

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities-9.680.553.12-0.90-9.39
Net Cash used in Investing Activities0.18-0.401.12-0.74-2.33
Net Cash used in Financing Activities9.60-0.21-4.231.319.61

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue38.4520.7917.9317.7221.75
Total Expenses41.8724.2019.8527.2525.12
Profit Before Tax-4.55-3.96-2.41-9.61-3.85
Profit After Tax-4.57-3.96-2.41-9.61-3.88
Operating Profit after Depreciation-3.32-3.21-1.85-8.88-3.21

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue38.4520.7917.9317.7221.75
Total Expenses36.6019.2817.6517.3420.66
Profit Before Tax0.720.96-0.210.300.61
Profit After Tax0.720.96-0.210.300.58
Operating Profit after Depreciation1.951.710.351.031.25

Brooks Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 116.87
S2 113.98
S3 109.92
Pivot 120.93
R1 123.82
R2 127.88
R3 130.77

Moving Average

20 SMA 142.11
50 SMA 159.55
100 SMA 150.38
200 SMA 127.94

Brooks Laboratories Ltd Corporate Actions

No available data

Brooks Laboratories Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Brooks Laboratories Ltd ₹117.40 ₹308.14
Sun Pharmaceuticals Industries Ltd ₹1,613.65 ₹3,87,168.69
Divis Laboratories Ltd ₹5,725.20 ₹1,51,986.07
Cipla Ltd ₹1,463.25 ₹1,18,174.12
Torrent Pharmaceuticals Ltd ₹3,028.40 ₹1,02,490.21
Mankind Pharma Ltd ₹2,337.05 ₹96,421.67

Brooks Laboratories Ltd News

Brooks Laboratories to declare Quarterly Results

On 13 February 2025

11 Feb 2025, 01:40 pm

Brooks Laboratories EGM scheduled

On 11 January 2025

21 Dec 2024, 09:53 am

Brooks Laboratories to conduct board meeting

On 11 December 2024

09 Dec 2024, 09:31 am

Brooks Laboratories schedules board meeting

On 9 November 2024

08 Nov 2024, 08:35 pm

Brooks Laboratories to conduct AGM

On 19 September 2024

03 Sep 2024, 05:24 pm

Brooks Laboratories Ltd Stock Analysis

  1. Annual revenue for Brooks Laboratories Ltd increased by 44.54% to ₹80.44 crore in FY 2024 from ₹55.65 crore in FY 2023.
  2. Annual Net Profit for Brooks Laboratories Ltd decreased by 118.68% to ₹1.53 crore in FY 2024 from ₹-8.18 crore in FY 2023.
  3. Promoter Shareholding in Brooks Laboratories Ltd decreased by 10.90% in the most recent quarter, from 59.06% in December 2024 to 52.62% in January 2025.
  4. Brooks Laboratories Ltd delivered a 1-year return of -5.48% compared to the Nifty 50, which provided a return of 1.92% as of the last trading session.
  5. Brooks Laboratories Ltd share price moved down by 3.16% from its previous close of INR ₹119.75. The latest Brooks Laboratories Ltd share price is INR ₹115.97.
  6. Brooks Laboratories Ltd share price today has been at a low of 115.31 and a high of 123.72. Over the past 52 weeks, the Brooks Laboratories Ltd share price has seen a low of 73.25 and a high of 198.86.

FAQ’s

What is the share price of Brooks Laboratories Ltd today?

Brooks Laboratories Ltd share price as on 26 Feb 2025 is ₹ 115.97

What is the Market Cap of Brooks Laboratories Ltd?

The market cap of Brooks Laboratories Ltd stock is ₹304.38 Cr.

What is the PE Ratio of Brooks Laboratories Ltd?

The Price to Earnings (P/E) Ratio of Brooks Laboratories Ltd is 160

What is the PB Ratio of Brooks Laboratories Ltd?

The Price to Book (P/B) Ratio of Brooks Laboratories Ltd is 3.50

What is the 52 week high of Brooks Laboratories Ltd Share Price?

The 52 week high of Brooks Laboratories Ltd share price stands at ₹198.86

What is the 52 week low of Brooks Laboratories Ltd Share Price?

The 52 week low of Brooks Laboratories Ltd share price stands at ₹73.25

Get started with us today and
start building your wealth journey